Clayton Anita H, Montejo Angel L
Department of Psychiatric Medicine, University of Virginia Health System, Charlottesville, 22908, USA.
J Clin Psychiatry. 2006;67 Suppl 6:33-7.
Sexual dysfunction is a common problem with a number of causes, including psychosocial factors, general medical illness, psychiatric disorders, and psychotropic and nonpsychiatric medications. It is especially prevalent among patients with poor emotional health and has been strongly associated with antidepressant medications. Selective serotonin reuptake inhibitors (SSRIs) in particular have demonstrated a higher incidence of sexual dysfunction than other antidepressants that work through different mechanisms of action. Further supporting the relationship between sexual dysfunction and antidepressant mechanism of action, data from a number of studies indicate that bupropion, nefazodone, and mirtazapine alleviate symptoms of sexual dysfunction and are as effective as SSRIs at controlling depressive symptoms. Although a number of strategies besides drug substitution have been utilized to help manage antidepressant-induced sexual dysfunction, many patients remain suboptimally treated; as many as 42% of patients were found to passively wait for spontaneous remission. The addition of antidotal therapy has been proven to be among the effective management strategies for sexual dysfunction. However, due to a lack of systematic data, additional studies are warranted to further investigate these findings.
性功能障碍是一个常见问题,其病因众多,包括心理社会因素、一般躯体疾病、精神障碍以及精神类和非精神类药物。它在情绪健康状况不佳的患者中尤为普遍,并且与抗抑郁药物密切相关。特别是选择性5-羟色胺再摄取抑制剂(SSRI)相比于其他通过不同作用机制起效的抗抑郁药,已显示出更高的性功能障碍发生率。多项研究的数据进一步支持了性功能障碍与抗抑郁药作用机制之间的关系,这些数据表明安非他酮、奈法唑酮和米氮平可缓解性功能障碍症状,且在控制抑郁症状方面与SSRI同样有效。尽管除了药物替代之外,还采用了多种策略来帮助处理抗抑郁药引起的性功能障碍,但许多患者的治疗效果仍未达到最佳;多达42%的患者被发现被动等待自行缓解。已证明添加解毒疗法是治疗性功能障碍的有效管理策略之一。然而,由于缺乏系统性数据,有必要开展更多研究以进一步探究这些发现。